Calliditas Therapeutics
CALT
$20.00
Share price
-0.25%
Change (1 day)
-17.70%
Change (1 year)
Categories
Calliditas Therapeutics (CALT) - P/B ratio
P/B ratio as of May 2024 : 15.3
According to Calliditas Therapeutics's latest financial reports the company has a price-to-book ratio of 15.3.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Calliditas Therapeutics - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 23.3 | 279.67% |
| 2022-12-31 | 6.14 | 5.64% |
| 2021-12-31 | 5.81 | 6.25% |
| 2020-12-31 | 5.47 | |
| 2019-12-31 | N/A | |
| 2018-12-31 | N/A | |
| 2017-12-31 | N/A |